Sign in
About
Ethics Policy
Privacy Policy
Refund Policy
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Thursday, March 5, 2026
Sign in / Join
About
Ethics Policy
Privacy Policy
Refund Policy
Facebook
Instagram
Twitter
Vimeo
Youtube
About
Ethics Policy
Privacy Policy
Refund Policy
Search
LATEST ARTICLES
Press Release
TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
Team Business Headline
-
December 7, 2025
0
Press Release
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
Team Business Headline
-
December 7, 2025
0
Press Release
Geekstake Reviews Risk Signals Across Multi-Chain Networks in Response to Global Economic Uncertainty
Team Business Headline
-
December 7, 2025
0
Press Release
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20...
Team Business Headline
-
December 6, 2025
0
Press Release
Copper Quest Closes $1,927,000 Private Placement
Team Business Headline
-
December 6, 2025
0
Press Release
HNI Corporation Announces Expiration and Final Results of Exchange Offer
Team Business Headline
-
December 6, 2025
0
Press Release
Webus International Limited Issues Clarification on Previous Announcement Related to Expedia Group
Team Business Headline
-
December 6, 2025
0
Press Release
Colabor Group Announces Resignation of Director
Team Business Headline
-
December 6, 2025
0
Press Release
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and Previously Treated NSCLC Patients with EGFR Atypical...
Team Business Headline
-
December 5, 2025
0
Press Release
Transcenta Therapeutics Presents Updated Efficacy Data from the Phase I/II Transtar102 Trial of Osemitamab plus Nivolumab and CAPOX in First-Line G/GEJ Cancer at ESMO...
Team Business Headline
-
December 5, 2025
0
1
...
46
47
48
...
287
Page 47 of 287
Most Popular
Decisions of the Extraordinary General Meeting of shareholders of Nordic Fibreboard AS
March 4, 2026
Director/PDMR Shareholding
March 4, 2026
Final Results
March 4, 2026
Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
March 4, 2026
Load more
Recent Comments
yearlymagazine
on
Market: Ola Electric Mobility Shares Tank 5% Today
yearlymagazine
on
Future of Startup Funding in 2025: A Steady Rebound with a Focus on Sustainable Growth
yearlymagazine
on
Future of Startup Funding in 2025: A Steady Rebound with a Focus on Sustainable Growth
yearlymagazine
on
Unimech Aerospace and Manufacturing IPO: Stellar Response and Strong Grey Market Performance
influencersginewuld
on
12 Indian Startups That Shut Down This Year: Report
error:
Recent Comments